Progress in the development of small molecular inhibitors of the Bruton’s tyrosine kinase (BTK) as a promising cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Progress in the development of small molecular inhibitors of the Bruton’s tyrosine kinase (BTK) as a promising cancer therapy

Published:2021-10 Issue: Volume:47 Page:116358
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Liu Xiu-Juan,Xu-Liu ,Pang Xiao-Jing,-Ying Yuan Xin,Yu Guang-Xi,Li Yin-Ru,Guan Yong-Feng,Zhang Yan-Bing,Song Jian,Zhang Qiu-Rong,Zhang Sai-Yang

Funder

China Association for Science and Technology

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Science and Technology Department of Henan Province

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference142 articles.

1. Tec family kinases in T lymphocyte development and function;Berg;Annu Rev Immunol,2005

2. Tec family kinases in lymphocyte signaling and function;Schaeffer;Curr Opin Immunol,2000

3. The Bruton Tyrosine Kinase (BTK) Inhibitor Acalabrutinib Demonstrates Potent On-Target Effects and Efficacy in Two Mouse Models of Chronic Lymphocytic Leukemia;Herman;Clinical cancer research : an official journal of the American Association for Cancer Research,2017

4. Mechanisms of B-cell lymphoma pathogenesis;Küppers;Nat Rev Cancer,2005

5. Role of Bruton's tyrosine kinase in B cells and malignancies;Pal Singh;Molecular cancer,2018

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Pharmacokinetic Interaction of Tirabrutinib with Voriconazole, Itraconazole, and Fluconazole in SD Rats by UPLC-MS/MS;Current Medicinal Chemistry;2024-10

2. Evaluation of infectious morbidity due to BTK inhibitors in indolent B-cell lymphomas: latest research findings and systematic analysis;Expert Opinion on Pharmacotherapy;2024-07-23

3. Targeted small molecule therapy and inhibitors for lymphoma;Future Medicinal Chemistry;2024-07-17

4. Discovery of a novel BTK inhibitor S-016 and identification of a new strategy for the treatment of lymphomas including BTK inhibitor-resistant lymphomas;Acta Pharmacologica Sinica;2024-06-04

5. Annual review of PROTAC degraders as anticancer agents in 2022;European Journal of Medicinal Chemistry;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3